Literature DB >> 15207811

The PDGF family: four gene products form five dimeric isoforms.

Linda Fredriksson1, Hong Li, Ulf Eriksson.   

Abstract

Platelet-derived growth factors (PDGFs) were discovered more than two decades ago. Today the PDGF family of growth factors consists of five different disulphide-linked dimers built up of four different polypeptide chains encoded by four different genes. These isoforms, PDGF-AA, PDGF-AB, PDGF-BB, PDGF-CC and PDGF-DD, act via two receptor tyrosine kinases, PDGF receptors alpha and beta. The classic PDGFs, PDGF-A and PDGF-B, undergo intracellular activation during transport in the exocytic pathway for subsequent secretion, while the novel PDGFs, PDGF-C and PDGF-D, are secreted as latent factors that require activation by extracellular proteases. The classical PDGF polypeptide chains, PDGF-A and PDGF-B, are well studied and they regulate several physiological and pathophysiological processes, mainly using cells of mesenchymal or neuroectodermal origin as their targets. The discovery of two additional ligands for the two PDGF receptors suggests that PDGF-mediated cellular signaling is more complex than previously thought.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15207811     DOI: 10.1016/j.cytogfr.2004.03.007

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  230 in total

1.  Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity.

Authors:  Youngmi Kim; Eunhee Kim; Qiulian Wu; Olga Guryanova; Masahiro Hitomi; Justin D Lathia; David Serwanski; Andrew E Sloan; Robert J Weil; Jeongwu Lee; Akiko Nishiyama; Shideng Bao; Anita B Hjelmeland; Jeremy N Rich
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

Review 2.  PPARgamma as a potential therapeutic target in pulmonary hypertension.

Authors:  Roy L Sutliff; Bum-Yong Kang; C Michael Hart
Journal:  Ther Adv Respir Dis       Date:  2010-06       Impact factor: 4.031

Review 3.  Progress of molecular targeted therapies for prostate cancers.

Authors:  Weihua Fu; Elena Madan; Marla Yee; Hongtao Zhang
Journal:  Biochim Biophys Acta       Date:  2011-11-29

4.  Structures of a platelet-derived growth factor/propeptide complex and a platelet-derived growth factor/receptor complex.

Authors:  Ann Hye-Ryong Shim; Heli Liu; Pamela J Focia; Xiaoyan Chen; P Charles Lin; Xiaolin He
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-02       Impact factor: 11.205

5.  Differential tumorigenic potential and matriptase activation between PDGF B versus PDGF D in prostate cancer.

Authors:  Abdo J Najy; Joshua J Won; Lisa S Movilla; Hyeong-Reh C Kim
Journal:  Mol Cancer Res       Date:  2012-06-11       Impact factor: 5.852

6.  Astrocytes and pericytes differentially modulate blood-brain barrier characteristics during development and hypoxic insult.

Authors:  Abraham Al Ahmad; Carole Bürgi Taboada; Max Gassmann; Omolara O Ogunshola
Journal:  J Cereb Blood Flow Metab       Date:  2010-09-08       Impact factor: 6.200

7.  Distribution and possible role of PDGF-AA and PDGFR-alpha in the gastrointestinal tract of adult guinea pigs.

Authors:  Fangxiao Chan; Yong Liu; Haimei Sun; Xiaoshuang Li; Hongwei Shang; Dongying Fan; Jing An; Deshan Zhou
Journal:  Virchows Arch       Date:  2010-07-15       Impact factor: 4.064

8.  TGFβ acts through PDGFRβ to activate mTORC1 via the Akt/PRAS40 axis and causes glomerular mesangial cell hypertrophy and matrix protein expression.

Authors:  Soumya Maity; Falguni Das; Balakuntalam S Kasinath; Nandini Ghosh-Choudhury; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2020-07-30       Impact factor: 5.157

9.  Peptide arrays for development of PDGFRβ Affine molecules.

Authors:  Annabell Marr; Felix Nissen; Daniel Maisch; Annette Altmann; Shoaib Rana; Jürgen Debus; Peter E Huber; Uwe Haberkorn; Vasileios Askoxylakis
Journal:  Mol Imaging Biol       Date:  2013-08       Impact factor: 3.488

10.  Blocking SDF-1α/CXCR4 downregulates PDGF-B and inhibits bone marrow-derived pericyte differentiation and tumor vascular expansion in Ewing tumors.

Authors:  Randala Hamdan; Zhichao Zhou; Eugenie S Kleinerman
Journal:  Mol Cancer Ther       Date:  2013-11-26       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.